非性运动障碍的神经外科治疗
Sean D McEvoy1, David D Limbrick1, Jeffrey Steven Raskin2,3
1Department of Neurological Surgery, Washington University School of Medicine in St. Louis, Brookings, MO, USA.
概括
儿科非性运动障碍,如 dystonia,通常需要神经外科干预. 深度大脑刺激和息切除术是关键的治疗方法,而根茎切除术对于这些具有挑战性的疾病仍未得到充分研究.
科学领域:
- 儿科神经学 儿科神经学
- 神经外科 神经外科
- 运动障碍 运动障碍
背景情况:
- 非性运动障碍在儿童中很普遍,经常表现为超运动类型,如 dystonia,tics,chorea 和 tremor.
- 这些疾病是由各种遗传和遗传原因引起的,尽管有现有治疗方法,但这些疾病会对儿童的功能能力产生重大影响.
- 神经外科干预对于治疗严重的儿科运动障碍至关重要.
研究的目的:
- 对儿科非性运动障碍的当前神经外科管理策略进行审查.
- 评价关于儿科患者的息切除术,根茎切除术和深度大脑刺激的文献.
- 发现关于儿童运动障碍的特定神经外科技术的研究缺陷.
主要方法:
- 使用PubMed进行了专注的文献审查,搜索了用英语发表的文章.
- 搜索术语包括"利切除术", "带切除术", "深度大脑刺激", "dystonia", "儿童", "青少年" 和 "儿科".
- 文章被审查是否与儿科运动障碍的神经外科治疗相关.
主要成果:
- 这项搜索从2004年到2023年产生了37篇文章,其中大多数专注于深度大脑刺激 (34篇文章).
- 帕利多托米被涵盖在3篇文章中,没有文章专门涉及草根.
- 深度大脑刺激是对儿科运动障碍最常被研究的神经外科干预的方法.
结论:
- 神经外科手术,包括息切除术,根茎切除术和深度大脑刺激,对于儿科 dystonia 管理至关重要.
- 利切除术可能适用于特定的患者群体,例如那些患有性状态或高硬件并发症风险的患者.
- 根茎手术是一种未得到充分利用的选择,需要进一步的研究来确定其在儿科患者群体中的疗效和安全性.
更多相关视频
07:20Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
Published on: August 9, 2024
1.2K
08:25Combined Invasive Subcortical and Non-invasive Surface Neurophysiological Recordings for the Assessment of Cognitive and Emotional Functions in Humans
Published on: May 19, 2016
10.8K
相关概念视频
Skeletal Muscle Relaxants: Therapeutic Uses
514
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
514
Parkinson's Disease: Overview
598
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
598
